For super-resolution microscopes, AI helps by restoring images from even noisy, low-fluorescence data. That capability helps ...
News-Medical.Net on MSN
AI turns routine pathology slides into powerful maps of the tumor immune landscape
A large study shows that routine H&E pathology slides contain rich spatial proteomic signals that can be decoded by AI to ...
SHENZHEN, CHINA - Media OutReach Newswire - 9 December 2025 - On November 16, the 27th China Hi-Tech Fair (CHTF) successfully ...
The biochips market is poised for robust growth driven by technological advancements and increased healthcare needs. Opportunities abound in diagnostics, drug discovery, and personalized medicine, ...
The Melanoma Research Alliance launched a national biorepository at the University of Colorado to collect melanoma samples, focusing on rare subtypes for diagnostic and treatment research.
Vietnam Investment Review on MSN
27th China Hi-Tech Fair closes with 170 billion RMB deals in Shenzhen
The 27th China Hi-Tech Fair concluded successfully this November with 170 billion RMB deals, igniting the future of technology in Shenzhen.
The global Proteomics Market is on a rapid growth trajectory, projected to reach USD 134.82 billion by 2035 from an estimated USD 44.79 billion in 2025, reflecting a robust CAGR of 11.7%. Driven by ...
Genes steadily associated with prognosis define conserved mitotic and immune programs that robustly predict cancer patient survival and therapeutic resistance across tumor types.
Injectable peptides that people use to build muscle, shed weight and appear younger, are on the rise in the U.S. and trending among influencers, celebrities and fitness coaches, despite the fact that ...
Australian biotech innovator Vaxxas has secured a major milestone in its journey to revolutionise vaccine delivery. The ...
If you’ve been clued into the peptides conversation, you might also be wonder what the best peptide skin-care products can do for you. This “silent powerhouse” (there are, in fact, various types of ...
North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results